Beeken Biomedical specializes in advanced hemostatic surgical dressings, particularly through its NuStat® product line, which is designed for the rapid control of bleeding in various medical scenarios. The NuStat® family of products utilizes a patented technology known as Hemafiber™, which consists of a matrix of hemostatic clotting fibers. This innovative technology works by absorbing blood and concentrating clotting factors at the wound site, thereby accelerating the formation of clots and facilitating immediate hemostasis. The products are indicated for use in situations involving class III or class IV bleeding, as well as for severely bleeding wounds resulting from surgical procedures or traumatic injuries.

In addition to their application in surgical settings, Beeken Biomedical's products are also tailored for public safety use, catering to first responders such as military personnel, police, firefighters, and emergency medical services. The NuStat® products are designed to meet or exceed the specifications set by the U.S. Department of Defense, ensuring high standards of quality and functionality. By focusing on the development and commercialization of these innovative wound care solutions, Beeken Biomedical aims to enhance the capabilities of healthcare providers and first responders in managing critical bleeding situations effectively.

United States

Beeken Biomedical is an medical device company focused on the development, licensing and commercialization of wound care products. Beeken Biomedical introduces innovative and cost-effective technologies that rapidly stop bleeding and help protect wounds from infection. Beeken Biomedical is committed to improve solutions in wound care for healthcare professionals and consumers.

Beeken Biomedical

Company Details